Marpai, Inc. (MRAI)
| Market Cap | 93.90M +235.2% |
| Revenue (ttm) | 16.64M -29.7% |
| Net Income | -16.89M |
| EPS | -0.75 |
| Shares Out | 26.83M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 13,574 |
| Open | 3.430 |
| Previous Close | 3.430 |
| Day's Range | 3.200 - 3.500 |
| 52-Week Range | 0.215 - 4.160 |
| Beta | 4.66 |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Nov 13, 2026 |
About Marpai
Marpai, Inc., together with its subsidiaries, operates as a technology-driven healthcare payer company in the United States. The company provides third-party administrator and value-oriented health plan services to employers that directly pay for employee health benefits. It also offers in-house ancillary services that include clinical care management, a nurse-led guide for at-risk members across the care continuum; repricing insights, which are out-of-network claims; Marpai PACCS, a pharmacy advocacy cost containment solution that is a member-... [Read more]
Financial Performance
In 2025, Marpai's revenue was $18.10 million, a decrease of -35.76% compared to the previous year's $28.17 million. Losses were -$16.56 million, -25.03% less than in 2024.
Financial StatementsNews
Marpai Expands Relationship with Claritev to Help Reduce Healthcare Costs for Employer Clients
MCLEAN, Va.--(BUSINESS WIRE)---- $CTEV #ClaimsManagement--Claritev Corporation (NYSE: CTEV), a healthcare technology, data, and insights company, today announced that Marpai, Inc. (OTCQX: MRAI) has ex...
Marpai Reports Second Quarter 2026 Financial Results
Successful turnaround leads to lower operating costs and improved gross margin; debt restructuring and subsequent financing strengthen capital structure TAMPA, Fla., Aug. 13, 2026 /PRNewswire/ -- Marp...
Marpai Quarterly report: Q2 2026
Marpai has published its Q2 2026 quarterly earnings report on August 13, 2026.
Marpai Earnings release: Q2 2026
Marpai released its Q2 2026 earnings on August 13, 2026, summarizing the period's financial results.
Marpai Announces $12 Million Private Placement led by Mitchell Companies
TAMPA, Fla., July 29, 2026 /PRNewswire/ -- Marpai, Inc. ("Marpai" or the "Company") (OTCQX: MRAI), a leader in innovative healthcare technology, Third-Party Administration ("TPA"), and Pharmacy Benefi...
Marpai Inc. Announces Debt Restructuring Agreements with JGB Capital and AXA, Reducing Debt Service by $26.4 Million Through 2027 and Enhances Near term Liquidity
Debt restructuring aligns capital structure, with projected operational cash flows, and unlocks capital for growth TAMPA, Fla., July 20, 2026 /PRNewswire/ -- Marpai, Inc. ("Marpai" or the "Company") (...
Marpai Inc. Announces Unprecedented Growth with 192,000 New Estimated Member Lives Across TPA and MarpaiRx PBM Platforms; Expects to Achieve Positive Cash Flow and EBITDA Beginning August 2026
TAMPA, Fla., May 26, 2026 /PRNewswire/ -- Marpai, Inc. ("Marpai" or the "Company") (OTCQX: MRAI), a leader in innovative healthcare technology, Third-Party Administration ("TPA"), and Pharmacy Benefit...
MARPAI REPORTS FIRST QUARTER 2026 FINANCIAL RESULTS
Strategic Investments in Operations and Technology Fuel Platform for Accelerated Growth and Aim of Second-Half 2026 Profitability TAMPA, Fla., May 15, 2026 /PRNewswire/ -- Marpai, Inc. ("Marpai" or th...
Marpai Quarterly report: Q1 2026
Marpai has published its Q1 2026 quarterly earnings report on May 15, 2026.
Marpai, Inc. Announces Significant New Business Wins across TPA and MarpaiRx; Solidifies Forecast for Profitability
TAMPA, Fla., May 11, 2026 /PRNewswire/ -- Marpai, Inc. ("Marpai" or the "Company") (OTCQX: MRAI), a leader in innovative healthcare technology, Third-Party Administration ("TPA"), and Pharmacy Benefit...
Marpai, Inc. Secures Major Strategic Marketing Collaboration to Continue Acceleration of MarpaiRx Growth Nationwide
TAMPA, Fla., April 1, 2026 /PRNewswire/ -- Marpai, Inc. ("Marpai" or the "Company") (OTCQX: MRAI), a leader in innovative healthcare technology, Third-Party Administration (TPA), and Pharmacy Benefit ...
Marpai Secures Access to Network Creating Major Growth Catalyst for MarpaiRx Representing Up to 1.5 million Covered Lives
Marketing Agreement Establishes Powerful National Distribution Channel and Expands Marpai's Revenue Growth Opportunity TAMPA, Fla., March 9, 2026 /PRNewswire/ -- Marpai, Inc. ("Marpai" or the "Company...
Marpai Annual report: Q4 2025
Marpai has published its Q4 2025 annual report on February 25, 2026.
Marpai, Inc. Secures Major Strategic Wins for MarpaiRx, Adding Over 19,000 Lives and Accelerating High-Growth Platform Expansion
New Client Momentum Highlights Rapid Adoption of Marpai's Disruptive, Scalable Healthcare Platform Positioned to Drive Exponential Revenue Growth and Long-Term Shareholder Value TAMPA, Fla., Feb. 23, ...
MARPAI, INC. HIRES PHARMACY EXECUTIVE MIMI DAVIS AS PRESIDENT OF MARPAIRX TO DRIVE STRATEGIC GROWTH
TAMPA, Fla., Jan. 27, 2026 /PRNewswire/ -- Marpai, Inc. ("Marpai" or the "Company") (OTCQX: MRAI), a leader in innovative healthcare technology, Pharmacy Benefit Management (PBM) and Third-Party Admin...
MARPAI ANNOUNCES 2026 MOMENTUM AND KEY PARTNERSHIP EXPANSION
Renews Aetna Signature Administrator Network Agreement and Enhances Cost Containment with Faircost Optimizer TAMPA, Fla. , Dec. 1, 2025 /PRNewswire/ -- Marpai, Inc. ("Marpai" or the "Company") (OTCQX:...
Marpai Earnings Call Transcript: Q3 2025
Q3 2025 saw a 42% revenue decline but improved operating efficiency and reduced losses. New client wins, a $3.9M capital raise, and technology upgrades position the company for growth in a rapidly expanding TPA market.
Marpai Quarterly report: Q3 2025
Marpai has published its Q3 2025 quarterly earnings report on November 13, 2025.
Marpai Earnings release: Q3 2025
Marpai released its Q3 2025 earnings on November 13, 2025, summarizing the period's financial results.
MARPAI REPORTS THIRD QUARTER 2025 FINANCIAL RESULTS
Continued Turnaround Driven by Cost Discipline and Operational Efficiency; Positioned for Strong 2026 Growth TAMPA, Fla. , Nov. 12, 2025 /PRNewswire/ -- Marpai, Inc. ("Marpai" or the "Company") (OTCQX...
MARPAI TO HOST WEBCAST ON NOVEMBER 13, 2025 TO DISCUSS THIRD QUARTER 2025 FINANCIAL RESULTS
TAMPA, Fla. , Nov. 6, 2025 /PRNewswire/ -- Marpai, Inc. ("Marpai" or the "Company") (OTCQX: MRAI), a leader in innovative healthcare technology and Third-Party Administration (TPA) services.
MARPAI RECOGNIZED AS 2025 TOP THIRD PARTY ADMINISTRATOR
Recognition Highlights Company's Stellar Reputation and Technology-Driven Approach to Smarter Healthcare and Real Savings TAMPA, Fla. , Oct. 14, 2025 /PRNewswire/ -- Marpai, Inc. ("Marpai" or the "Com...
MARPAI, INC. RECEIVES ADDITIONAL $200,000 INVESTMENT FROM DAMIEN LAMENDOLA'S HILLCOUR INVESTMENT FUND
A Total of $1.7 Million Raised in Q3 2025 TAMPA, Fla. , Oct. 6, 2025 /PRNewswire/ -- Marpai, Inc. ("Marpai" or the "Company") (OTCQX: MRAI), an independent national Third-Party Administration ("TPA") ...
Marpai Earnings Call Transcript: Q2 2025
Q2 2025 saw a 35% revenue decline but significant improvements in operating expenses and net loss, reflecting strategic exits from unprofitable contracts. The relaunch of MarpaiRx and ongoing cost reductions position the company for profitability in Q1 2026.
Marpai Quarterly report: Q2 2025
Marpai has published its Q2 2025 quarterly earnings report on August 14, 2025.